Mark J. Gergen, Senior VP, Corporate Development at AMYLIN PHARMACEUTICALS INC (AMLN), sold 1,000 shares at $50.00 ($50K) on 2007-09-04, disclosed to the SEC on 2007-09-06.
Scheduled sale ($50k) by Senior VP, Corporate Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.00 | 500 | $25K | 49.5% |
| 2 | $50.00 | 500 | $25K | 50.5% |
| Total | $49.50 avg | 1,000 | $50K | 100% |
| Filing → |
| MRTX | SELL | 2016-01-19 | $518K | — | Filing → |
| AMLN | SELL | 2012-03-02 | $32K | — | Filing → |
| AMLN | SELL | 2012-02-24 | $128K | — | Filing → |